Search Results - "van’t Hof, Arnoud W.J."

Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes by KATRITSIS, Demosthenes G, SIONTIS, George C. M, KASTRATI, Adnan, VAN'T HOF, Arnoud W. J, NEUMANN, Franz-Josef, SIONTIS, Konstantinos C. M, IOANNIDIS, John P. A

“…An invasive approach is superior to medical management for the treatment of patients with acute coronary syndromes without ST-segment elevation (NSTE-ACS), but…”
Get full text

Effectiveness of Home-Based Mobile Guided Cardiac Rehabilitation as Alternative Strategy for Nonparticipation in Clinic-Based Cardiac Rehabilitation Among Elderly Patients in Europe: A Randomized Clinical Trial by Snoek, Johan A, Prescott, Eva I, van der Velde, Astrid E, Eijsvogels, Thijs M H, Mikkelsen, Nicolai, Prins, Leonie F, Bruins, Wendy, Meindersma, Esther, González-Juanatey, José R, Peña-Gil, Carlos, González-Salvado, Violeta, Moatemri, Feriel, Iliou, Marie-Christine, Marcin, Thimo, Eser, Prisca, Wilhelm, Matthias, Van't Hof, Arnoud W J, de Kluiver, Ed P

“…Although nonparticipation in cardiac rehabilitation is known to increase cardiovascular mortality and hospital readmissions, more than half of patients with…”
Get more information

Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors by De Luca, Giuseppe, Gibson, C. Michael, Bellandi, Francesco, Noc, Marko, Dudek, Dariusz, Zeymer, Uwe, Arntz, Hans-Richard, Cutlip, Donald, Maioli, Mauro, Zorman, Simona, Mesquita Gabriel, H, Emre, Ayse, Rakowski, Tomasz, Gyongyosi, Mariann, Huber, Kurt, van’t Hof, Arnoud W.J

“…Abstract Background It has been shown that, among patients with ST-segment elevation myocardial infarction (STEMI), diabetes is associated with a significantly…”
Get full text

Prognostic assessment of patients with acute Myocardial Infarction treated with primary angioplasty: Implications for early discharge by DE LUCA, Giuseppe, SURYAPRANATA, Harry, VAN'T HOF, Arnoud W. J, DE BOER, Menko-Jan, HOORNTJE, Jan C. A, DAMBRINK, Jan-Henk E, GOSSELINK, A. T, OTTERVANGER, Jan Paul, ZIJLSTRA, Felix

“…The aim of this study was to create a practical score for risk stratification in patients with ST-segment elevation myocardial infarction (STEMI) treated with…”
Get full text

Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty by De Luca, Giuseppe, van't Hof, Arnoud W.J, de Boer, Menko-Jan, Ottervanger, Jan Paul, Hoorntje, Jan C.A, Gosselink, A.T.Marcel, Dambrink, Jan-Henk E, Zijlstra, Felix, Suryapranata, Harry

“…Aims The prognostic role of time-to-treatment in primary angioplasty is still a matter of debate. The aim of our study was to evaluate the relationship between…”
Get full text

Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction by Timmer, Jorik R., Ottervanger, Jan Paul, de Boer, Menko-Jan, Dambrink, Jan-Henk E., Hoorntje, Jan C.A., Gosselink, A.T. Marcel, Suryapranata, Harry, Zijlstra, Felix, van't Hof, Arnoud W.J.

“…This study was designed to investigate whether elevated glucose is associated with impaired Thrombolysis In Myocardial Infarction (TIMI) flow before primary…”
Get full text

Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction by Ernst, Nicolette M.S.K.J., Suryapranata, Harry, Miedema, Kor, Slingerland, Robbert J., Ottervanger, Jan Paul, Hoorntje, Jan C.A., Gosselink, A.T.Marcel, Dambrink, Jan-Henk E., de Boer, Menko-Jan, Zijlstra, Felix, van’t Hof, Arnoud W.J.

“…To evaluate the extent of platelet aggregation inhibition in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary…”
Get full text

Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus-Eluting Stents in Acute Myocardial Infarction by Hofma, Sjoerd H., MD, PhD, Brouwer, Jan, MD, PhD, Velders, Matthijs A., MD, van't Hof, Arnoud W.J., MD, PhD, Smits, Pieter C., MD, PhD, Queré, Michel, MD, de Vries, Cornelis Jan, MD, van Boven, Adrianus J., MD, PhD

“…Objectives The goal of this study was to compare the efficacy and safety of second-generation everolimus-eluting stents (EES) with first-generation…”
Get full text

Prognostic importance of creatine kinase and creatine kinase–MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction by Nienhuis, Mark B., MD, Ottervanger, Jan Paul, MD, PhD, de Boer, Menko-Jan, MD, PhD, Dambrink, Jan-Henk E., MD, PhD, Hoorntje, Jan C.A., MD, PhD, Gosselink, A.T. Marcel, MD, PhD, Suryapranata, Harry, MD, PhD, van't Hof, Arnoud W.J., MD, PhD

“…Background Although the prognostic significance of creatine kinase (CK) and creatine kinase–MB (CK-MB) after myocardial infarction has been established after…”
Get full text

Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials by De Luca, Giuseppe, Smits, Peter, Hofma, Sjoerd H, Di Lorenzo, Emilio, Vlachojannis, Georgios J, van't Hof, Arnoud W.J, van Boven, Ad J, Kedhi, Elvin, Stone, Gregg W, Suryapranata, Harry

“…Abstract Background Several concerns have emerged about the higher risk of very late stent thrombosis (ST) with first generation drug-eluting stent (DES)…”
Get full text

Long-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent Thrombosis : An Analysis of 431 Cases by VAN WERKUM, Jochem W, HEESTERMANS, Antonius A. C. M, VAN'T HOF, Arnoud W. J, VERHEUGT, Freek W. A, TEN BERG, Jurriën M, DE KORTE, Fleur I, KELDER, Johannes C, SUTTORP, Maarten-Jan, RENSING, Benno J. W. M, ZWART, Bastiaan, GUUS BRUEREN, B. R, KOOLEN, Jacques J, DAMBRINK, Jan-Henk E

“…There are limited data on the long-term clinical outcome after an angiographically confirmed (definite) stent thrombosis (ST). Four hundred thirty-one…”
Get full text

Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: Optimization of antiplatelet treatment in patients 70 years and older—rationale and design of the POPular AGE study by Qaderdan, Khalid, MD, Ishak, Maycel, MD, Heestermans, Antonius A.C.M., MD, PhD, de Vrey, Evelyn, MD, Jukema, J. Wouter, MD, PhD, FESC, Voskuil, Michiel, MD, PhD, de Boer, Menko-Jan, MD, PhD, FESC, van‘t Hof, Arnoud W.J., MD, PhD, Groenemeijer, Björn E., MD, PhD, Vos, Gerrit-Jan A., MD, Janssen, Paul W.A., MD, Bergmeijer, Thomas O., MD, Kelder, Johannes C., MD, PhD, Deneer, Vera H.M., PharmD, PhD, ten Berg, Jurriën M., MD, PhD, FESC

“…Rationale Dual antiplatelet therapy with acetylsalicylic acid in combination with a more potent P2Y12- inhibitor (ticagrelor or prasugrel) is recommended in…”
Get full text

Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty by De Luca, Giuseppe, Suryapranata, Harry, Zijlstra, Felix, van't Hof, Arnoud W.J, Hoorntje, Jan C.A, Gosselink, A.T.Marcel, Dambrink, Jan-Henk, de Boer, Menko-Jan

“…The aim of the study was to evaluate the relationship between symptom-onset-to-balloon time and one-year mortality in patients with ST-segment elevation…”
Get full text

Thrombus aspiration and prehospital ticagrelor administration in ST-elevation myocardial infarction: Findings from the ATLANTIC trial by Kilic, Sinem, Fabris, Enrico, van't Hof, Arnoud W.J, Hamm, Christian W., Lapostolle, Frédéric, Lassen, Jens Flensted, Tsatsaris, Anne, Diallo, Abdourahmane, Vicaut, Eric, Montalescot, Gilles

“…The potential interactions between prehospital (pre-H) ticagrelor administration and thrombus aspiration (TA) in patients with ST-elevation myocardial…”
Get full text

Guide extension, unmissable tool in the armamentarium of modern interventional cardiology. A comprehensive review by Fabris, Enrico, Kennedy, Mark, Di Mario, Carlo, Sinagra, Gianfranco, Roolvink, Vincent, Ottervanger, Jan Paul, Hof, Arnoud van't, Kedhi, Elvin

“…Abstract Due to the aging population undergoing percutaneous coronary intervention (PCI), interventional cardiologists are confronted daily with treatment of…”
Get full text

Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failure by DE LUCA, Giuseppe, VAN'T HOF, Arnoud W. J, DE BOER, Menko-Jan, HOORNTJE, Jan C. A, GOSSELINK, A. T, DAMBRINK, Jan-Henk E, OTTERVANGER, Jan Paul, ZIJLSTRA, Felix, SURYAPRANATA, Harry

“…The aim of the present study was to investigate the prognostic implication of myocardial perfusion in patients with ST-segment-elevation myocardial infarction…”
Get full text

Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial by Gargiulo, Giuseppe, da Costa, Bruno R, Frigoli, Enrico, Palmieri, Cataldo, Nazzaro, Marco Stefano, Falcone, Camillo, Liso, Armando, Vigna, Carlo, Abate, Fabio, Comeglio, Marco, Diletti, Roberto, Gabrielli, Gabriele, Di Lorenzo, Emilio, Mazzarotto, Pietro, Zimarino, Marco, Moretti, Claudio, Colombo, Antonio, Penzo, Carlo, Pasquetto, Giampaolo, Brugaletta, Salvatore, Ferrari, Fabio, Casu, Gavino, Guiducci, Vincenzo, Dellavalle, Antonio, Liistro, Francesco, Mauro, Ciro, Van't Hof, Arnoud W J, Omerovic, Elmir, Curello, Salvatore, de la Torre Hernandez, Jose Maria, De Servi, Stefano, Belloni, Flavia, Windecker, Stephan, Valgimigli, Marco

“…Our aim was to assess whether bivalirudin compared with unfractionated heparin (UFH) is associated with consistent outcomes in males and females with acute…”
Get more information

Frequency and prognostic significance of access site and non-access site bleeding and impact of choice of antithrombin therapy in patients undergoing primary percutaneous coronary intervention. The EUROMAX trial by Kilic, Sinem, van't Hof, Arnoud W.J, ten Berg, Jurrien, Lopez, Ana Ayesta, Zeymer, Uwe, Hamon, Martial, Soulat, Louis, Bernstein, Debra, Deliargyris, Efthymios N, Steg, Phillippe Gabriel

“…Abstract Background The overall impact of post percutaneous coronary intervention (PCI) bleeding on long term prognosis after an acute coronary syndromes (ACS)…”
Get full text

Impact of Time from Symptom Onset to Drug Administration on Outcome in Patients Undergoing Glycoprotein IIb-IIIa Facilitated Primary Angioplasty (from the EGYPT Cooperation) by De Luca, Giuseppe, MD, van't Hof, Arnoud W.J., MD, Gibson, C. Michael, MD, Cutlip, Donald, MD, Zeymer, Uwe, MD, Noc, Marko, MD, Maioli, Mauro, MD, Zorman, Simona, MD, Gabriel, H. Mesquita, MD, Emre, Ayse, MD, Rakowski, Tomasz, MD, Gyongyosi, Maryann, MD, Huber, Kurt, MD, Bellandi, Francesco, MD, Dudek, Dariusz, MD

“…Contrasting data have been so far reported on facilitation with glycoprotein IIb-IIIa inhibitors (GpIIbIIIa) in patients who underwent primary percutaneous…”
Get full text

Iliofemoral Tortuosity Increases the Risk of Access-Site-Related Complications After Aortic Valve Implantation and Plug-Based Access-Site Closure by Lux, Arpad, Müllenberg, Lisa, Veenstra, Leo F., Kats, Suzanne, Maesen, Bart, van’t Hof, Arnoud W.J.

“…Access-site-related complications are often related to high-risk anatomy and technical pitfalls and impair the outcomes of transfemoral aortic valve…”
Get full text